Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.

Financial Strength

7/10

Name	Current	Vs Industry
Cash-To-Debt	0.24
Equity-to-Asset	0.56
Debt-to-Equity	0.64
Debt-to-EBITDA	14.34
Interest Coverage	2.21
Piotroski F-Score	N/A/9	0 1 2 3 4 5 6 7 8 9

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

	Name	Current	Vs Industry		Vs History
	5-Day RSI	21.26
	9-Day RSI	33.73
	14-Day RSI	38.52

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.05
	Quick Ratio	1.45
	Cash Ratio	0.39
	Days Inventory	551.85
	Days Sales Outstanding	384.26
	Days Payable	111.61

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	3.37
	Forward Dividend Yield %	3.37
	5-Year Yield-on-Cost %	3.37

Profitability Rank

1/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	40.79
	Operating Margin %	17.1
	Net Margin %	7.66
	FCF Margin %	-26.78
	ROE %	1.98
	ROA %	1.1
	ROIC %	2.25
	ROC (Joel Greenblatt) %	2.91
	ROCE %	3.15

GF Value Rank

	Name	Current	Vs Industry		Vs History
	PE Ratio	56.51
	PE Ratio without NRI	56.51
	PS Ratio	4.61
	PB Ratio	1.19
	Price-to-Tangible-Book	1.19
	Price-to-Operating-Cash-Flow	162.56
	EV-to-EBIT	37.78
	EV-to-EBITDA	37.78
	EV-to-Revenue	6.48
	EV-to-FCF	-24.31
	Price-to-Graham-Number	1.73
	Earnings Yield (Greenblatt) %	2.65
	FCF Yield %	-5.81

Financials

Annual Quarterly TTM

DHA:TECHNODRUG's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

No Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

No Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

No Enough Data

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

No Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015

Techno Drugs Ltd Executives

Details

GF Value

DHA:TECHNODRUG

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with TECHNODRUG. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil BDT)	1,020.405
	EPS (TTM) (BDT)	0.63
	Beta	0
	Volatility %	0
	14-Day RSI	38.52
	14-Day ATR (BDT)	1.289282
	20-Day SMA (BDT)	36.965
	12-1 Month Momentum %	0
	52-Week Range (BDT)	29 - 69.7
	Shares Outstanding (Mil)	132

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	9999
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Techno Drugs Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Techno Drugs Ltd Stock Events

Financials Calendars

	Event	Date	Price(BDT)
No Event Data

Techno Drugs Ltd Frequently Asked Questions

What is Techno Drugs Ltd(DHA:TECHNODRUG)'s stock price today?

The current price of DHA:TECHNODRUG is BDT35.60. The 52 week high of DHA:TECHNODRUG is BDT69.70 and 52 week low is BDT29.00.

When is next earnings date of Techno Drugs Ltd(DHA:TECHNODRUG)?

The next earnings date of Techno Drugs Ltd(DHA:TECHNODRUG) is .

Does Techno Drugs Ltd(DHA:TECHNODRUG) pay dividends? If so, how much?

The Dividend Yield % of Techno Drugs Ltd(DHA:TECHNODRUG) is 3.37% (As of Today), Highest Dividend Payout Ratio of Techno Drugs Ltd(DHA:TECHNODRUG) was 0. The lowest was 0. And the median was 0. The Forward Dividend Yield % of Techno Drugs Ltd(DHA:TECHNODRUG) is 3.37%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
No Press Release

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.